Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pierre Laurin Insider Profile
4 Followers
Pierre Laurin, President & Chief Executive Officer at Liminal BioSciences, holds 368.50K shares in Ortho Regenerative Technologies (Ticker: ORTIF), holds 12.32M shares in Liminal BioSciences (Ticker: LMNL). Most recently, Pierre Laurin Bought ― shares of Ortho Regenerative Technologies on Aug 24, 2020 for an estimated value of 100.00K.
Pierre Laurin Liminal BioSciences (LMNL)President & Chief Executive Officer
Liminal BioSciences (LMNL)
President & Chief Executive Officer
Ranked #2,447 out of 78,624 Corporate Insiders
Profitable Transactions
17 out of 22 Profitable Transactions
Average Return
+22.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pierre Laurin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 25, 2015 - Aug 25, 2016
Return:+81.00%
The most profitable trade made by Pierre Laurin
Pierre Laurin's Trading History
Liminal BioSciences
Dec 11, 2017
President & Chief Executive Officer
Uninformative Sell
―
$50.99M
Ortho Regenerative Technologies
Aug 24, 2020
Director
Informative Buy
100.00K
$213.73K
List of latest transactions for each holding click on a transaction to see Pierre Laurin's performance on stock
You May Also Like
Pierre Laurin insider profile FAQ
What is the percentage of profitable transactions made by Pierre Laurin?
The percentage of profitable transactions made by Pierre Laurin is 77%.
What is the average return per transaction made by Pierre Laurin?
The average return per transaction made by Pierre Laurin is 22.00%.
What stocks does Pierre Laurin hold?
Pierre Laurin holds: LMNL, ORTIF stocks.
What was Pierre Laurin’s latest transaction?
Pierre Laurin latest transaction was an Informative Buy of $100.00K.
What was Pierre Laurin's most profitable transaction?
Pierre Laurin’s most profitable transaction was an Informative Buy of LMNL stock on August 25, 2015. The return on the trade was 81.00%.
What is Pierre Laurin's role in Liminal BioSciences?
Pierre Laurin's role in Liminal BioSciences is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.